Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Insmed Inc (INSM)

  • Company Report
  • Feb. 23, 2023, 15:54 UTC
  • 46

New SEC Filing for Insmed Incorporated (NASDAQ:INSM)

Comment Full text

Immunic Inc (IMUX)

  • Company Report
  • Feb. 23, 2023, 15:24 UTC
  • 45

New SEC Filing for Immunic Inc. (NASDAQ:IMUX)

Comment Full text

Moderna Inc (MRNA)

  • Company Report
  • Feb. 23, 2023, 15:10 UTC
  • 48

Moderna - Fourth Quarter 2022

Comment Full text

ICON plc (ICLR)

  • Company Report
  • Feb. 23, 2023, 00:35 UTC
  • 47

ICON Reports Fourth Quarter and Full Year 2022 Results

Comment Full text

Glaukos Corporation (GKOS)

  • Company Report
  • Feb. 23, 2023, 00:10 UTC
  • 47

Glaukos - Fourth Quarter 2022

Comment Full text

Eli Lilly and Company (LLY)

  • Company Report
  • Feb. 22, 2023, 18:34 UTC
  • 47

New Form 10-K for Eli Lilly and Company

Comment Full text

Cytokinetics Inc (CYTK)

  • Company Report
  • Feb. 22, 2023, 15:35 UTC
  • 44

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

Comment Full text

Dermata Therapeutics Inc. (DRMA)

  • Company Report
  • Feb. 22, 2023, 00:29 UTC
  • 45

New SEC Form for Dermata Therapeutics, Inc.

Comment Full text

Halozyme Therapeutics Inc (HALO)

  • Company Report
  • Feb. 22, 2023, 00:05 UTC
  • 47

Halozyme - Fourth Quarter 2022

Comment Full text

Luna Innovations Incorporated (LUNA)

  • Company Report
  • Feb. 21, 2023, 23:34 UTC
  • 45

Luna Announces Fourth-Quarter and Full-Year 2022 Financial Release Date of March 14, 2023

Comment Full text
  • Previous
  • 27
  • 28
  • 29
  • 30
  • 31
  • Next

Search

News categories

  • Technical Exchange News(9311)
  • Event(407)
  • SEC News(150442)
  • FDA Approval(8583)
  • Company Report(721)
  • Business News(103437)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin